Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the international union of basic and clinical pharmacology

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 1, 2010, Pages 531-559

  Orme, Michael ^a   Sjçqvist, Folke ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; CLINICAL PHARMACOLOGY; CLINICAL RESEARCH; CURRICULUM; DRUG INDUSTRY; GOVERNMENT; HEALTH CARE POLICY; KNOWLEDGE; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT CARE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; TEACHING;

DRUG;

BIOMEDICAL RESEARCH; DELIVERY OF HEALTH CARE; HUMANS; INTERNATIONALITY; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; SOCIETIES, SCIENTIFIC; TEACHING;

EID: 77953866148     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00602.x     Document Type: Review

References (75)

1. Clinical Pharmacology Scope, Organisation, Training. Report of a WHO Study group. World Health Organ Tech Rep Ser 1970;446:521.
2. World Health Organization. Guidelines for the Development of National Drug Policies. World Health Organization Geneva, 1988.
3. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976 33 : 792 795.
4. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008 65 : 573 579.
5. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J 2004 329 : 15 9. (Pubitemid 38869995)
6. Aronson JK. Medication errors: what they are, how they happen and how to avoid them. QJM 2009 102 : 513 521.
7. Aronson JK. Clinical pharmacology and therapeutics in the UK - a great instauration. Br J Clin Pharmacol 2010 69 : 111 117.
8. Horton R. The UK's NHS and pharma: from schism to symbiosis. Lancet 2009 373 : 435 436.
9. Dollery CT. Clinical pharmacology the first 75 years and a view of the future. Br J Clin Pharmacol 2006 61 : 650 655.
10. Reidenberg MM. The discipline of clinical pharmacology. Clin Pharmacol Ther 1985 38 : 2 5.
11. Shelley JH, Baur MP. Paul Martini: the first clinical pharmacologist? Lancet 1999 353 : 1870 1873.
12. Lasagna L. Clinical pharmacology: present status and future development. Science 1966 15 : 388 391.
13. Lasagna L. Clinical pharmacology in the United States: a personal reminiscence. Annu Rev Pharmacol Toxicol 1985 25 : 27 31.
14. Kalow W. Pharmacogenetics. COWS, editor
15. Motulsky AG. Drug reactions, enzymes, and biochemical genetics. J Am Med Assoc 1957 165 : 835 837.
16. Dangoumau J. The origins of clinical pharmacology in France. Therapie 2002 57 : 6 26.
17. Clinical Pharmacology. The European Challenge. WHO Regional Publications, European Series 1991, No. 39.
18. Food and Drug Administration. Challenge and Opportunity on the Critical Path to New Medicinal Products. US Department of Health and Human Services Bethesda, 2004.
19. European Medicines Agency. The European Medicines Agency Road Map to 2010: preparing the Ground for the Future. EMEA/H/34163/03/Final
20. Anon. Triple therapy. The Economist. 14 August 2008. http://www. economist.com/people/displaystory.cfm?story-id=11919385 (last accessed on 6 September 2008).
21. Rawlins MD. De Testimonio. http://www/rcplondon.ac.uk/pubs/contents/ 304df931-2ddc-4a54-894e-e0cdb03e84a5.pdf (last accessed on 10 January 2010).
22. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002 359 : 1373 1378.
23. Flockhart DA, Usdin YS, Pezzullo JC, Knollman BC. Teaching rational prescribing: a new clinical pharmacology curriculum in medical schools. Naunyn Schmiedebergs Arch Pharmakol 2002 366 : 33 43.
24. Gwee MC. Teaching of medical pharmacology: the need to nurture the early development of desicured attitude for safe and rational drug prescribing. Med Teach 2009 31 : 847 854.
25. Heaton A, Webb DJ, Maxwell SRJ. Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol 2008 66 : 128 134.
26. Smith A, Tasioulas T, Cockayne N, Misan G, Walker G, Quick G. Construction and evaluation of a web-based interactive prescribing curriculum for senior medical students. Br J Clin Pharmacol 2006 62 : 653 659.
27. Maxwell SRJ, McQueen DS, Ellaway R. eDrug: a dynamic interactive electronic drug formulary for medical students. Br J Clin Pharmacol 2006 62 : 673 681.
28. Clinical Pharmacological Services. Report on a working group, Bonn, April 26-29, 1977. WHO Regional Office for Europe.
29. Blaschke TF. Global challenges for clinical pharmacology in the developing world. Clin Pharmacol Ther 2009 85 : 579 581.
30. Engelberg AB, Kesselheim AS, Avorn J. Balancing innovation, access, and profits-market exclusivity for biologics. N Engl J Med 2009 361 : 1917 1919.
31. Sjöqvist F, Bergman U, Dahl ML, Gustafsson L, Hensjö LO. Drug and therapeutics committees: a Swedish experience. Drug Inf J 2002 16 : 207 213.
32. Sjöborg B, Bäckström T, Arvidsson LB et al. Design and implementation of "point of care" computerised system for drug therapy in Stockholm metropolitan health region - bridging the gap between knowledge and practice. Int J Med Inform 2007 76 : 497 506.
33. Breckenridge A, Woods K, Walley T. Medicines regulation and health technology assessment. Clin Pharmacol Ther 2010 87 : 152 154.
34. Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res 2009 9 : 65 83.
35. Reidenberg MM. Can the selection of essential medicines decrease inappropriate drug use? Clin Pharmacol Ther 2009 85 : 581 583.
36. Crooks J. Drug epidemiology and clinical pharmacology: their contribution to patient care. Br J Clin Pharmacol 1983 16 : 351 357.
37. Introduction to Drug Utilization Research. World Health Organisation, Geneva, 2003.
38. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990 263 : 549 556.
39. Moore N. The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Saf 2001 24 : 1 7.
40. Phillips E, Mallal S. Successful translation of pharmacogenetics into the clinic: the abacavir example. Mol Diagn Ther 2009 13 : 1 9.
41. Eklöf A, Thurelius A, Garle M, Rane A, Sjöqvist F. The anti doping hot-line, a means to detect and prevent the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 2003 59 : 571 577.
42. Böttiger Y, Laine K, Andersson ML et al. Sfinx - a drug-drug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol 2009 65 : 627 633.
43. Lewis P. The clinical pharmacologist in drug discovery and development. Br J Clin Pharmacol 1996 42 : 133 136.
44. Vane J, O'Grady J. Clinical pharmacology in the pharmaceutical industry. Br J Clin Pharmacol 1991 31 : 155 157.
45. Baber NS. The scope of clinical pharmacology in the pharmaceutical industry. Br J Clin Pharmacol 1991 31 : 495 496.
46. International ethical guidelines for biomedical research involving human subjects. The Council for International Organizations of Medical Sciences (CIOMS). http://www.cioms.ch/frame-guidelines-nov-2002.htm 2002. (last accessed on 6 October 2009).
47. Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. WHO Technical Report Series, No. 850, Annex 3, World Health Organization. http://www.who.int/medicines/library/par/ggcp/GGCP.shtml 1995. (last accessed on 6 October 2009).
48. International conference of harmonization (ICH). E6: good clinical practice: consolidated guideline. http://www.ich.org/cache/compo/276-254-1.html (last accessed on 4 June 2005).
49. WHO Policy Perspective on Medicines No 7 "Effective Medicines Regulation: Ensuring Safety, Efficacy and Quality", November 2003, World Health Organization. http://www.who.int/medicines/organization/mgt/ PolicyPerspectives.shtml (last accessed on 25 September 2009).
50. EMEA Mission Statement. http://www.ema.europa.eu/mission.htm (last accessed on 26 May 2010).
51. Smith AJ, McGettigan P. Quality use of medicines in the community: the Australian experience. Br J Clin Pharmacol 2000 50 : 515 519.
52. Wang X, Hripcsak G, Markatou M, Friedman C. Active computerized pharmacovigilance using natural language processing, statistics and electronic health records: a feasibility study. J Am Med Inform Assoc 2009 16 : 328 337.
53. Lesko LJ. Paving the Critical Path: how can Clinical Pharmacology Help Achieve the Vision? Clin Pharmacol Ther 2007 81 : 170 177.
54. Massol J, Puech A, Boissel JP. How to anticipate the assessment of the public health benefit of new medicines? Therapie 2007 62 : 427 435.
55. Grabowski H. Follow-on biologics: data exclusivity and the balance between innovation and competition. Nat Rev Drug Discov 2008 7 : 479 488.
56. Giezen TJ, Mantel-Teeuwisse AK, Straus SMJM, Schellekens H, Leufkens HGM, Egberts ACG. Safety-related regulatory actions for biologicals approved in the United States and the European Union. J Am Med Assoc 2008 300 : 1887 1896.
57. Frank RG. Regulation of follow-on biologics. N Engl J Med 2007 357 : 841 843.
58. Bennett CL, Luminari S, Nissenson AR et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004 351 : 1403 1408.
59. Gottlieb S. Biosimilars: policy, clinical and regulatory considerations. Am J Health Syst Pharm 2008 65 : S2 8.
60. Roger SD, Goldsmith D. Biosimilars: it's not as simple as cost alone. J Clin Pharm Ther 2008 33 : 459 464.
61. Declerck PJ. Biotherapeutics in the era of biosimilars: what really matters is patient safety. Drug Saf 2007 30 : 1087 1092.
62. Holloway K Irrational use of medicines: Global challenges and actions. World Health Organisation, Harvard Medical School and Harvard Pilgrim Health. Medicines Use in Primary Care in Developing Countries and Transitional Countries: Fact Book Summarizing Results from Studies Reported between 1990 and 2006. WHO
63. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2004 2 (4 e100.
64. WHO database of Adverse Drug Reactions. http://www.who.int/medicines/ area/quality-safety/safety-efficacy/advdrugreactions/en/ (last accessed on 26 May 2010).
65. United Nations High Commissioner for Human Rights. Universal Declaration of Human Rights, 1948. http://donegallpass.org/UNIVERSAL-DECLARATION-OF-HUMAN- RIGHTS.pdf (last accessed on 26 May 2010).
66. Hogerzeil HV, Samson M, Casanovas JV, Rahmani-Ocora L. Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? Lancet 2006 368 : 305 311.
67. The World Bank, Data and Statistics, 2005. International Comparison Program -Results. http://www.worldbank.org/data/icp (last accessed on 26 May 2010).
68. Laing R., Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001 16 : 13 20.
69. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumour appearance in young women. N Engl J Med 1971 284 : 878 881.
70. Fraser HS. Clinical pharmacology in developing countries. Br J Clin Pharmacol 1981 11 : 457 459.
71. Richens A, Routledge P. Essential of clinical pharmacology for education and research in developing countries. Br J Clin Pharmacol 1984 18 : 123 126.
72. Folb PI. The future of clinical pharmacology in South Africa. CME 1991 9 : 1485 1490.
73. Mucklow J. Postgraduate education in clinical pharmacology and therapeutics. Br J Clin Pharmacol 1998 45 : 339 346.
74. Royal College of Physicians. Specialty Training Curriculum for Clinical Pharmacology and Therapeutics. Joint Royal Colleges of Physicians Training Board
75. Gray J, Lewis L, Nierenberg D. Clinical pharmacology education in primary care residency programs. Clin Pharmacol Ther 1997 62 : 237 240.